Robert S Radie is Director of ROCKWELL MEDICAL, INC.. Currently has a direct ownership of 93,525 shares of RMTI, which is worth approximately $200,143. The most recent transaction as insider was on May 21, 2024, when has been sold 36,111 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.5K
0% 3M change
30.42% 12M change
Total Value Held $200,143

Robert S Radie Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
36,111 Added 27.86%
93,525 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
24,715 Added 15.53%
134,404 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 18.56%
109,689 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 37.12%
84,689 Common Stock

Also insider at

PRTK
Paratek Pharmaceuticals, Inc. Healthcare
RSR

Robert S Radie

Director
Boston, MA

Track Institutional and Insider Activities on RMTI

Follow ROCKWELL MEDICAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMTI shares.

Notify only if

Insider Trading

Get notified when an Rockwell Medical, Inc. insider buys or sells RMTI shares.

Notify only if

News

Receive news related to ROCKWELL MEDICAL, INC.

Track Activities on RMTI